Publisher's Synopsis
This book is the first detailed case study of how the social security and tort systems have responded to the challenge posed by latent industrial disease in Great Britain. The opening chapters discuss the arbitrary and incomplete coverage provided through these mechanisms. Particular attention is paid to the narrow basis for prescribing diseases under the industrial injuries scheme. The book examines the development of medical and scientific knowledge as to the aetiology of asbestos û related diseases and how compensation schemes have reacted to these changes. The reasons for delays both in identifying such diseases and securing compensation for them are analysed, and in particular the delays in establishing prescription of some of these diseases for benefit purposes. The reasons for the low success rates in benefit claims are considered in the light of the differing legal and medical concepts of proof. The slow development of regulatory standards to protect the health and safety of asbestos workers is also examined. Where, appropriate, comparative references are made to developments in Europe and North America. The book concludes by seeking to place the findings of this case study within the general debate on compensation for personal injuries.
